Results 181 to 190 of about 8,092 (217)
Some of the next articles are maybe not open access.

ADAR1 mutation causes ZBP1-dependent immunopathology

Nature, 2022
The RNA-editing enzyme ADAR1 is essential for the suppression of innate immune activation and pathology caused by aberrant recognition of self-RNA, a role it carries out by disrupting the duplex structure of endogenous double-stranded RNA species1,2. A point mutation in the sequence encoding the Z-DNA-binding domain (ZBD) of ADAR1 is associated with ...
Nicholas W Hubbard   +2 more
exaly   +3 more sources

ADAR1 prevents autoinflammation by suppressing spontaneous ZBP1 activation

open access: yesNature, 2022
The RNA-editing enzyme adenosine deaminase acting on RNA 1 (ADAR1) limits the accumulation of endogenous immunostimulatory double-stranded RNA (dsRNA)1. In humans, reduced ADAR1 activity causes the severe inflammatory disease Aicardi-Goutières syndrome (AGS)2. In mice, complete loss of ADAR1 activity is embryonically lethal3-6, and mutations similar to
Richard de Reuver   +2 more
exaly   +3 more sources

SINEs of cancer therapy success without ADAR1

Nature Reviews Molecular Cell Biology, 2020
RNA editing by ADAR1 destabilizes epigenetic-treatment-induced retrotransposon stem–loops and thus dampens the immune response to the treatment, suggesting that ADAR1 could be a therapeutic target in combination with epigenetic therapy.
exaly   +3 more sources

The anti-apoptotic function of ADAR1 [PDF]

open access: yesNature Reviews Molecular Cell Biology, 2017
exaly   +2 more sources

ADAR1 Biology Can Hinder Effective Antiviral RNA Interference

Journal of Virology, 2023
All life at the cellular level has the capacity to induce an antiviral response. Here, we examine the result of imposing the antiviral response of one branch of life onto another and find evidence for conflict.
Skyler Uhl   +5 more
openaire   +2 more sources

ADAR1 entraps sinister cellular dsRNAs, thresholding antiviral responses

Trends in Immunology, 2021
ADAR1 edits adenosines to inosines in cellular double-stranded (ds)RNA, thereby preventing aberrant activation of antiviral dsRNA sensors, as well as interferon (IFN) induction in Aicardi-Goutières syndrome (AGS) encephalopathy. Recently, Nakahama et al., Tang et al., Maurano et al., and de Reuver et al.
Liam P. Keegan   +2 more
openaire   +2 more sources

CPEB3 suppresses gastric cancer progression by inhibiting ADAR1-mediated RNA editing via localizing ADAR1 mRNA to P bodies

Oncogene, 2022
Deciphering the crosstalk between RNA-binding proteins and corresponding RNAs will provide a better understanding of gastric cancer (GC) progression. The comprehensive bioinformatics study identified cytoplasmic polyadenylation element-binding protein 3 (CPEB3) might play a vital role in GC progression.
Jian Chen   +11 more
openaire   +2 more sources

Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown [PDF]

open access: yesCell, 2018
Type I interferon (IFN) is produced when host sensors detect foreign nucleic acids, but how sensors differentiate self from nonself nucleic acids, such as double-stranded RNA (dsRNA), is incompletely understood. Mutations in ADAR1, an adenosine-to-inosine editing enzyme of dsRNA, cause Aicardi-Goutières syndrome, an autoinflammatory disorder associated
Hachung Chung, Xianfang Wu, Tony Sun
exaly   +3 more sources

Home - About - Disclaimer - Privacy